Albuterol is generally considered safe to use during pregnancy, and major medical organizations recommend it as the preferred rescue inhaler for pregnant people with asthma. The National Asthma Education and Prevention Program specifically names albuterol as having a good safety profile during pregnancy. That said, the picture isn’t perfectly clean, and understanding the nuances helps you weigh the real risks against the very real dangers of uncontrolled asthma.
What Guidelines Recommend
The National Asthma Education and Prevention Program, whose guidelines are widely followed by allergists and obstetricians, recommends albuterol as the short-acting rescue inhaler of choice during pregnancy. It also recommends budesonide as the preferred inhaled corticosteroid for daily control. The reasoning is straightforward: both drugs have the most human safety data of any options in their class, and the consequences of poorly controlled asthma during pregnancy are well documented and serious.
The FDA label for albuterol states there are no adequate, well-controlled studies in pregnant women and advises using it “only if the potential benefit justifies the potential risk to the fetus.” That language sounds cautious, but it’s standard boilerplate for most medications. In practice, the benefit of breathing normally during pregnancy almost always outweighs theoretical risks from a rescue inhaler.
Why Uncontrolled Asthma Is the Bigger Threat
When asthma flares go untreated, oxygen levels drop for both you and the baby. A large meta-analysis published in PLoS One found that maternal asthma increased the risk of several serious complications: preterm birth by 18%, low birth weight by 29%, fetal growth restriction by 32%, and perinatal mortality by 24%. There was also a small but measurable increase in the risk of the baby not getting enough oxygen during delivery.
These aren’t rare edge cases. They reflect what happens across thousands of pregnancies when asthma isn’t well managed. The consistent message from the research is that the danger of skipping your inhaler and letting symptoms spiral is far greater than the risk of using it.
What the Animal and Human Data Show
Animal studies have raised some flags, though they require context. In mice, albuterol given by injection caused cleft palate in about 4.5% to 9.3% of offspring, depending on the dose. In rabbits, very high oral doses (roughly 60 times the maximum recommended human inhaled dose) caused skull defects. These studies used routes and doses that don’t reflect how a pregnant person actually uses an inhaler, where far less medication reaches the bloodstream.
Human data is more mixed but also more relevant. A large CDC-funded study, the National Birth Defects Prevention Study covering 1997 to 2011, found associations between early pregnancy bronchodilator use and certain rare birth defects, including cleft palate and cleft lip (about 1.5 times the background risk) and limb deficiencies (about 2.4 times the background risk). These are statistical associations, not confirmed causes, and the absolute risk remains very small since these defects are rare to begin with. The FDA label notes that despite decades of worldwide use, “no consistent pattern of defects can be discerned, and a relationship between albuterol use and congenital anomalies has not been established.”
How Much Reaches the Baby
Albuterol does cross the placenta. Lab studies using perfused human placental tissue found that about 12% of the drug transfers from the maternal side to the fetal side, driven by simple diffusion. That’s a meaningful fraction, but the amount that enters your bloodstream from an inhaler is already small compared to oral or IV dosing. This is a key reason inhaled albuterol is considered safer than oral forms: less drug circulates systemically, so less reaches the baby.
When albuterol has been given in high oral doses to delay preterm labor (a use that’s separate from asthma treatment), it has been associated with temporary increases in both maternal and fetal heart rate and drops in maternal blood pressure. These effects have not been seen with standard inhaled doses.
Long-Term Effects on Child Development
A 2023 cohort study published in JAMA Network Open followed over 91,000 mother-child pairs and tracked developmental milestones through the first three years of life. Children exposed to albuterol and similar medications in utero showed no differences in communication, gross motor skills, fine motor skills, or problem-solving ability compared to unexposed children. One small signal appeared: exposure in mid-to-late pregnancy was linked to a slight delay in personal-social skills, but the overall conclusion was that these medications are safe for fetal neurodevelopment regardless of when during pregnancy they’re used.
Signs Your Asthma May Need Better Control
If you’re reaching for your rescue inhaler more than two days per week, that’s a signal your asthma isn’t well controlled. This is true whether you’re pregnant or not, but during pregnancy the stakes are higher because every poorly controlled flare reduces oxygen delivery to the baby. Rather than using more albuterol, the better approach is usually adding or adjusting a daily controller medication like an inhaled corticosteroid, which prevents flares from happening in the first place.
Pregnancy itself can change how asthma behaves. Roughly a third of pregnant people with asthma see their symptoms improve, a third stay the same, and a third get worse. Symptoms tend to peak between weeks 24 and 36, then ease in the final month. Staying on top of your control plan matters more during pregnancy than at any other time, because the goal isn’t just managing your comfort. It’s protecting the oxygen supply your baby depends on.
Effects During Labor and Delivery
Albuterol relaxes smooth muscle, including the uterus. When given intravenously during labor (at doses much higher than inhaler use), it has been shown to significantly decrease uterine contractions. This property is actually why drugs in its class have been used to delay preterm labor. Using a rescue inhaler during labor for an asthma flare is not expected to stall delivery, since inhaled doses produce far lower blood levels than IV administration. If you have asthma, keeping your inhaler accessible during labor is standard practice.